37 assets in Psychotic Disorder

Therapeutic assets addressing Psychotic Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Olanzapine Psychotic Disorder	Shanghai Jiao Tong University School of Medicine	P4	BBB (77)
Risperidone Psychotic Disorder	Northwell Health	P4	BBB (77)
Paliperidone Psychotic Disorder	Consorcio Centro de Investigación Biomédica en Red (CIBER)	P4	BBB (76)
Sertraline Psychotic Disorder	Northwell Health	P4	BBB (74)
Quetiapine Psychotic Disorder	Shanghai Jiao Tong University School of Medicine	P4	BBB (73)
Amisulpride Psychotic Disorder	Shanghai Jiao Tong University School of Medicine	P4	BB (71)
Lurasidone Psychotic Disorder	George West Mental Health Foundation d/b/a Skyland Trail	P4	BB (69)
Clozapine Psychotic Disorder	Jimmi Nielsen	P4	BB (68)
Lithium, Elemental Psychotic Disorder	Rakitzi, Stavroula	P4	BB (68)
Acetylcysteine Psychotic Disorder	National Taiwan University Hospital	P4	BB (65)
Metformin Psychotic Disorder	Nova Scotia Health Authority	P4	BB (64)
Serine D-Form Psychotic Disorder	University of Minnesota	P3	B (63)
Lumateperone Psychotic Disorder	University of New Mexico	P4	B (62)
Progesterone Psychotic Disorder	University of North Carolina, Chapel Hill	P4	B (62)
(S)-3,5-Dichloro-N-((1-Ethyl-2-Pyrrolidinyl)Methyl)-6-Hydroxy-O-Anisamide Psychotic Disorder	University of North Carolina, Chapel Hill	P4	B (62)
Oxytocin Psychotic Disorder	Charite University, Berlin, Germany	P2	B (60)
Karx-Ec Psychotic Disorder	Bristol-Myers Squibb	P3	B (57)
Karxt Psychotic Disorder	Bristol-Myers Squibb	P3	B (57)
Vortioxetine Psychotic Disorder	Fundación Pública Andaluza para la gestión de la Investigación en Sevilla	P2/3	B (57)
Human Immunoglobulins Psychotic Disorder	University of Cambridge	P2	CCC (53)
Modafinil Psychotic Disorder	University of Minnesota	P3	CCC (53)
Rituximab Psychotic Disorder	Uppsala University Hospital	P2	CCC (53)
Tirzepatide Psychotic Disorder	Anders Fink-Jensen, MD, DMSci	P2	CCC (53)
ly03010 Psychotic Disorder	Luye Pharma Group Ltd.	P1	CCC (48)
Memantine Psychotic Disorder	Bjorn H. Ebdrup	P1	CC (41)
Hyoscine Psychotic Disorder	Yale University	Early P1	C (38)
Rivastigmine Psychotic Disorder	Yale University	Early P1	C (38)
Fludeoxyglucose Psychotic Disorder	Universitaire Ziekenhuizen KU Leuven	N/A	D (30)
Maltodextrin Psychotic Disorder	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	N/A	D (30)
Melatonin Psychotic Disorder	Lahore General Hospital	N/A	D (30)
mk-6240 Psychotic Disorder	Universitaire Ziekenhuizen KU Leuven	N/A	D (30)
PE 2I Psychotic Disorder	Universitaire Ziekenhuizen KU Leuven	N/A	D (30)
SDM-8 Psychotic Disorder	Universitaire Ziekenhuizen KU Leuven	N/A	D (30)
Sodium Alginate Psychotic Disorder	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	N/A	D (30)
Pimavanserin Psychotic Disorder	Bjorn H. Ebdrup	P3	NR ()